RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2020

Jul 21, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2020-07-20

Reporting Person: Smith Hunter C (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-20	Stock Option (Right to Buy)	$22.53	A	25000	Acquired	2030-07-19	Common Stock (25000)	Direct

Footnotes

F1: The stock options were granted on July 20, 2020. The option vests and becomes exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.